Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 1-3, 2010, Pages 152-163

  Misra, Ranjita ^a   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

Intracellular drug delivery; MCF 7 cells; Nuclear localization signal; PLGA nanoparticles; Sustained release

Indexed keywords

DOXORUBICIN; NANOPARTICLE; POLYGLACTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER THERAPY; CELL CYCLE ARREST; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NUCLEAR LOCALIZATION SIGNAL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LACTIC ACID; NANOPARTICLES; NEOPLASMS; NUCLEAR LOCALIZATION SIGNALS; PHYSICOCHEMICAL PROCESSES; POLYGLYCOLIC ACID; SURFACE PROPERTIES;

EID: 74149089955     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.11.010     Document Type: Article

References (48)

1. Acharya S., Dilnawaz F., and Sahoo S.K. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30 (2009) 5737-5750
2. Adcock I.M., and Ito K. Molecular mechanisms of corticosteroid actions. Monaldi Arch Chest. Dis. 55 (2000) 256-266
3. Bisht S., and Maitra A. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Adv. Rev. 1 (2009) 415-425
4. Brana M.F., Cacho M., Gradillas A., de Pascual-Teresa B., and Ramos A. Intercalators as anticancer drugs. Curr. Pharm. Des. 7 (2001) 1745-1780
5. Cheng F.Y., Wang S.P., Su C.H., Tsai T.L., Wu P.C., Shieh D.B., Chen J.H., Hsieh P.C., and Yeh C.S. Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials 29 (2008) 2104-2112
6. Das M., Mohanty C., and Sahoo S.K. Ligand-based targeted therapy for cancer tissue. Expert Opin. Drug Deliv. 6 (2009) 285-304
7. Di X., Shiu R.P., Newsham I.F., and Gewirtz D.A. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem. Pharmacol. 77 (2009) 1139-1150
8. Futaki S., Nakase I., Suzuki T., Youjun Z., and Sugiura Y. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41 (2002) 7925-7930
9. Harashima H., Shinohara Y., and Kiwada H. Intracellular control of gene trafficking using liposomes as drug carriers. Eur. J. Pharm. Sci. 13 (2001) 85-89
10. Jain T.K., Morales M.A., Sahoo S.K., Leslie-Pelecky D.L., and Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2 (2005) 194-205
11. Jarver P., and Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 9 (2004) 395-402
12. Kalaria D.R., Sharma G., Beniwal V., and Ravi Kumar M.N. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm. Res. 26 (2009) 492-501
13. Kocbek P., Obermajer N., Cegnar M., Kos J., and Kristl J. Targeting cancer cells using plga nanoparticles surface modified with monoclonal antibody. J. Control. Release 120 (2007) 18-26
14. Kubota T., Furukawa T., Tanino H., Suto A., Otan Y., Watanabe M., Ikeda T., and Kitajima M. Resistant mechanisms of anthracyclines-pirarubicin might partly break through the p-glycoprotein-mediated drug-resistance of human breast cancer tissues. Breast Cancer 8 (2001) 333-338
15. Lee S.J., Jeong J.R., Shin S.C., Huh Y.M., Song H.T., Suh J.S., Chang Y.H., Jeon B.S., and Kim J.D. Intracellular translocation of superparamagnetic iron oxide nanoparticles encapsulated with peptide-conjugated poly (D, L lactide-co-glycolide). J. Appl. Phys. 97 (2005) 10Q913-1-3
16. Li, S., Zhou, Y., Wang, R., Zhang, H., Dong, Y., Ip, C., 2007. Selenium sensitizes mcf-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-akt and its downstream substrates. Mol. Cancer Ther. 6, 1031-1038.
17. Liu T.J., Yeh Y.C., Ting C.T., Lee W.L., Wang L.C., Lee H.W., Wang K.Y., Lai H.C., and Lai H.C. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes. Cardiovasc. Res. 80 (2008) 227-235
18. Liu Z.S., Tang S.L., and Ai Z.L. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma bel-7402 cells. World J. Gastroenterol. 9 (2003) 1968-1971
19. Lochmann D., Jauk E., and Zimmer A. Drug delivery of oligonucleotides by peptides. Eur. J. Pharm. Biopharm. 58 (2004) 237-251
20. Mi Y., and Lou L. Zd6474 reverses multidrug resistance by directly inhibiting the function of p-glycoprotein. Br. J. Cancer 97 (2007) 934-940
21. Mundargi R.C., Srirangarajan S., Agnihotri S.A., Patil S.A., Ravindra S., Setty S.B., and Aminabhavi T.M. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: In vitro and in vivo studies. J. Control. Release 119 (2007) 59-68
22. Nam Y.S., Park J.Y., Han S.H., and Chang I.S. Intracellular drug delivery using poly(d,l-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of hiv-1. Biotechnol. Lett. 24 (2002) 2093-2098
23. Noh W.C., Mondesire W.H., Peng J., Jian W., Zhang H., Dong J., Mills G.B., Hung M.C., and Meric-Bernstam F. Determinants of rapamycin sensitivity in breast cancer cells. Clin Cancer Res. 10 (2004) 1013-1023
24. Paine P.L., Moore L.C., and Horowitz S.B. Nuclear envelope permeability. Nature 254 (1975) 109-114
25. Pante N., and Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell 13 (2002) 425-434
26. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
27. Panyam J., and Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm. 1 (2003) 77-84
28. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., and Labhasetwar V. Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 16 (2002) 1217-1226
29. Parveen S., and Sahoo S.K. Polymeric nanoparticles for cancer therapy. J. Drug Target. 16 (2008) 108-123
30. Pouton C.W., Wagstaff K.M., Roth D.M., Moseley G.W., and Jans D.A. Targeted delivery to the nucleus. Adv. Drug Deliv. Rev. 59 (2007) 698-717
31. Prabha S., Zhou W.Z., Panyam J., and Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244 (2002) 105-115
32. Qaddoumi M.G., Gukasyan H.J., Davda J., Labhasetwar V., Kim K.J., and Lee V.H.L. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in plga nanoparticle endocytosis. Mol. Vision 9 (2003) 559-568
33. Sahoo S.K., and Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8 (2003) 1112-1120
34. Sahoo S.K., and Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2 (2005) 373-383
35. Sahoo S.K., Ma W., and Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 112 (2004) 335-340
36. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 82 (2002) 105-114
37. Sahoo S.K., Parveen S., and Panda J.J. The present and future of nanotechnology in human health care. Nanomedicine 3 (2007) 20-31
38. Schirmbeck R., Riedl P., Zurbriggen R., Akira S., and Reimann J. Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate toll-like receptor 9-dependent, but cd4+ t cell help-independent, priming of cd8+ t cells. J. Immunol. 171 (2003) 5198-5207
39. Sokolovskaya A.A., Zobotina T.N., Blokhin D.Y., Kadagidze Z.G., and Baryshnikov A.Y. Comparitive analysis of apoptosis induced by various anticancer drugs in jurkat cells. Exp. Oncol. 23 (2001) 46-50
40. Tan M.L., Choong P.F., and Dass C.R. Review: doxorubicin delivery systems based on chitosan for cancer therapy. J. Pharm. Pharmacol. 61 (2009) 131-142
41. Tewes F., Munnier E., Antoon B., Ngaboni Okassa L., Cohen-Jonathan S., Marchais H., Douziech-Eyrolles L., Souce M., Dubois P., and Chourpa I. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur. J. Pharm. Biopharm. 66 (2007) 488-492
42. Tkachenko A.G., Xie H., Liu Y., Coleman D., Ryan J., and Glomm W.R. Cellular trajectories of peptide-modified gold particle complexes: Comparision of nuclear localization signals and peptide transduction domains. Bioconjug. Chem. 15 (2004) 482-490
43. Vasir J.K., and Labhasetwar V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv. Drug Deliv. Rev. 59 (2007) 718-728
44. Wang S., Konorev E.A., Kotamraju S., Joseph J., Kalivendi S., and Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of h(2)o(2)- and p53-dependent pathways. J. Biol. Chem. 279 (2004) 25535-25543
45. Yamashita Y., Krauze M.T., Kawaguchi T., Noble C.O., Drummond D.C., Park J.W., and Bankiewicz K.S. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase ii inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro Oncol. 9 (2007) 20-28
46. You J., Hu F.Q., Du Y.Z., and Yuan H. Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles. Nanotechnology 19 (2008) 1-8
47. Zanta M.A., Belguise-Valladier P., and Behr J.P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A 96. (1999) 91-96
48. Zhang L., and Eisenberg A. Multiple morphologies of "Crew-cut" aggregates of polystyrene-b-poly(acrylic acid) block copolymers. Science 268 (1995) 1728-1731